Armin Sepp is the scientific leader and GSK associate fellow at GlaxoSmithKline. He received a Ph.D. in organic chemistry and enzyme kinetics, ‘The Reaction Mechanism of Chemically Modified Acetylcholinesterase’ from Tartu University in Estonia, Soros Scholar at Oxford University and MRC Immunochemistry Unit with Dr Alex Law, working on the chemical reactivity of complement factor C4. He has worked as a scientist at Gendaq Ltd, MRC LMB spinoff - protein engineering of Zn-finger proteins; senior scientist at Domantis Ltd, MRC LMB spinoff - protein engineering of domain antibodies using emulsion-based libraries; scientific investigator at GlaxoSmithKline, after acquisition of Domantis by GSK, working on domain antibody engineering but increasingly looking towards pharmacokinetics; and as a senior scientific investigator at GlaxoSmithKline, focusing on physiologically-based pharmacokinetics of biologics. He is
now scientific leader and GSK associate fellow at GlaxoSmithKline.